Table of Content

1 Granulocytes Monoclonal Antibody Market Overview
1.1 Granulocytes Monoclonal Antibody Product Overview
1.2 Granulocytes Monoclonal Antibody Market Segment by Type
1.2.1 Recombinant
1.2.2 Non-recombinant
1.3 Global Granulocytes Monoclonal Antibody Market Size by Type
1.3.1 Global Granulocytes Monoclonal Antibody Market Size Overview by Type (2024-2034)
1.3.2 Global Granulocytes Monoclonal Antibody Historic Market Size Review by Type (2024-2024)
1.3.3 Global Granulocytes Monoclonal Antibody Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Granulocytes Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.2 Europe Granulocytes Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Granulocytes Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Granulocytes Monoclonal Antibody Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Granulocytes Monoclonal Antibody Sales Breakdown by Type (2024-2024)
2 Global Granulocytes Monoclonal Antibody Market Competition by Company
2.1 Global Top Players by Granulocytes Monoclonal Antibody Sales (2024-2024)
2.2 Global Top Players by Granulocytes Monoclonal Antibody Revenue (2024-2024)
2.3 Global Top Players by Granulocytes Monoclonal Antibody Price (2024-2024)
2.4 Global Top Manufacturers Granulocytes Monoclonal Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Granulocytes Monoclonal Antibody Market Competitive Situation and Trends
2.5.1 Granulocytes Monoclonal Antibody Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Granulocytes Monoclonal Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Granulocytes Monoclonal Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into Granulocytes Monoclonal Antibody Market
2.8 Key Manufacturers Granulocytes Monoclonal Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Granulocytes Monoclonal Antibody Status and Outlook by Region
3.1 Global Granulocytes Monoclonal Antibody Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Granulocytes Monoclonal Antibody Historic Market Size by Region
3.2.1 Global Granulocytes Monoclonal Antibody Sales in Volume by Region (2024-2024)
3.2.2 Global Granulocytes Monoclonal Antibody Sales in Value by Region (2024-2024)
3.2.3 Global Granulocytes Monoclonal Antibody Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Granulocytes Monoclonal Antibody Forecasted Market Size by Region
3.3.1 Global Granulocytes Monoclonal Antibody Sales in Volume by Region (2024-2034)
3.3.2 Global Granulocytes Monoclonal Antibody Sales in Value by Region (2024-2034)
3.3.3 Global Granulocytes Monoclonal Antibody Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Granulocytes Monoclonal Antibody by Application
4.1 Granulocytes Monoclonal Antibody Market Segment by Application
4.1.1 Flow Cytometry
4.1.2 ELISA
4.1.3 Western Blot
4.1.4 Immunoprecipitation
4.1.5 Immunofluorescence
4.1.6 Other
4.2 Global Granulocytes Monoclonal Antibody Market Size by Application
4.2.1 Global Granulocytes Monoclonal Antibody Market Size Overview by Application (2024-2034)
4.2.2 Global Granulocytes Monoclonal Antibody Historic Market Size Review by Application (2024-2024)
4.2.3 Global Granulocytes Monoclonal Antibody Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Granulocytes Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.2 Europe Granulocytes Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Granulocytes Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Granulocytes Monoclonal Antibody Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Granulocytes Monoclonal Antibody Sales Breakdown by Application (2024-2024)
5 North America Granulocytes Monoclonal Antibody by Country
5.1 North America Granulocytes Monoclonal Antibody Historic Market Size by Country
5.1.1 North America Granulocytes Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2024)
5.1.3 North America Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2024)
5.2 North America Granulocytes Monoclonal Antibody Forecasted Market Size by Country
5.2.1 North America Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2034)
5.2.2 North America Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2034)
6 Europe Granulocytes Monoclonal Antibody by Country
6.1 Europe Granulocytes Monoclonal Antibody Historic Market Size by Country
6.1.1 Europe Granulocytes Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2024)
6.1.3 Europe Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2024)
6.2 Europe Granulocytes Monoclonal Antibody Forecasted Market Size by Country
6.2.1 Europe Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2034)
6.2.2 Europe Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2034)
7 Asia-Pacific Granulocytes Monoclonal Antibody by Region
7.1 Asia-Pacific Granulocytes Monoclonal Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Granulocytes Monoclonal Antibody Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Granulocytes Monoclonal Antibody Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Granulocytes Monoclonal Antibody Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Granulocytes Monoclonal Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Granulocytes Monoclonal Antibody Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Granulocytes Monoclonal Antibody Sales in Value by Region (2024-2034)
8 Latin America Granulocytes Monoclonal Antibody by Country
8.1 Latin America Granulocytes Monoclonal Antibody Historic Market Size by Country
8.1.1 Latin America Granulocytes Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2024)
8.1.3 Latin America Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2024)
8.2 Latin America Granulocytes Monoclonal Antibody Forecasted Market Size by Country
8.2.1 Latin America Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2034)
8.2.2 Latin America Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2034)
9 Middle East and Africa Granulocytes Monoclonal Antibody by Country
9.1 Middle East and Africa Granulocytes Monoclonal Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Granulocytes Monoclonal Antibody Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Granulocytes Monoclonal Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Granulocytes Monoclonal Antibody Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Granulocytes Monoclonal Antibody Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 LifeSpan BioSciences, Inc
10.1.1 LifeSpan BioSciences, Inc Company Information
10.1.2 LifeSpan BioSciences, Inc Introduction and Business Overview
10.1.3 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.1.4 LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Products Offered
10.1.5 LifeSpan BioSciences, Inc Recent Development
10.2 Thermo Fisher
10.2.1 Thermo Fisher Company Information
10.2.2 Thermo Fisher Introduction and Business Overview
10.2.3 Thermo Fisher Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Thermo Fisher Granulocytes Monoclonal Antibody Products Offered
10.2.5 Thermo Fisher Recent Development
10.3 RayBiotech, Inc.
10.3.1 RayBiotech, Inc. Company Information
10.3.2 RayBiotech, Inc. Introduction and Business Overview
10.3.3 RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.3.4 RayBiotech, Inc. Granulocytes Monoclonal Antibody Products Offered
10.3.5 RayBiotech, Inc. Recent Development
10.4 MyBiosource, Inc.
10.4.1 MyBiosource, Inc. Company Information
10.4.2 MyBiosource, Inc. Introduction and Business Overview
10.4.3 MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.4.4 MyBiosource, Inc. Granulocytes Monoclonal Antibody Products Offered
10.4.5 MyBiosource, Inc. Recent Development
10.5 Shanghai Korain Biotech Co., Ltd.
10.5.1 Shanghai Korain Biotech Co., Ltd. Company Information
10.5.2 Shanghai Korain Biotech Co., Ltd. Introduction and Business Overview
10.5.3 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Products Offered
10.5.5 Shanghai Korain Biotech Co., Ltd. Recent Development
10.6 Wuhan Fine Biotech Co., Ltd.
10.6.1 Wuhan Fine Biotech Co., Ltd. Company Information
10.6.2 Wuhan Fine Biotech Co., Ltd. Introduction and Business Overview
10.6.3 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Products Offered
10.6.5 Wuhan Fine Biotech Co., Ltd. Recent Development
10.7 CUSABIO
10.7.1 CUSABIO Company Information
10.7.2 CUSABIO Introduction and Business Overview
10.7.3 CUSABIO Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.7.4 CUSABIO Granulocytes Monoclonal Antibody Products Offered
10.7.5 CUSABIO Recent Development
10.8 Boster Biological Technology
10.8.1 Boster Biological Technology Company Information
10.8.2 Boster Biological Technology Introduction and Business Overview
10.8.3 Boster Biological Technology Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Boster Biological Technology Granulocytes Monoclonal Antibody Products Offered
10.8.5 Boster Biological Technology Recent Development
10.9 Biomatik
10.9.1 Biomatik Company Information
10.9.2 Biomatik Introduction and Business Overview
10.9.3 Biomatik Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Biomatik Granulocytes Monoclonal Antibody Products Offered
10.9.5 Biomatik Recent Development
10.10 Assay Genie
10.10.1 Assay Genie Company Information
10.10.2 Assay Genie Introduction and Business Overview
10.10.3 Assay Genie Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Assay Genie Granulocytes Monoclonal Antibody Products Offered
10.10.5 Assay Genie Recent Development
10.11 Abbexa
10.11.1 Abbexa Company Information
10.11.2 Abbexa Introduction and Business Overview
10.11.3 Abbexa Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Abbexa Granulocytes Monoclonal Antibody Products Offered
10.11.5 Abbexa Recent Development
10.12 CLOUD-CLONE CORP.
10.12.1 CLOUD-CLONE CORP. Company Information
10.12.2 CLOUD-CLONE CORP. Introduction and Business Overview
10.12.3 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.12.4 CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Products Offered
10.12.5 CLOUD-CLONE CORP. Recent Development
10.13 Innovative Research
10.13.1 Innovative Research Company Information
10.13.2 Innovative Research Introduction and Business Overview
10.13.3 Innovative Research Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Innovative Research Granulocytes Monoclonal Antibody Products Offered
10.13.5 Innovative Research Recent Development
10.14 ZodelBiotec Ltd.
10.14.1 ZodelBiotec Ltd. Company Information
10.14.2 ZodelBiotec Ltd. Introduction and Business Overview
10.14.3 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales, Revenue and Gross Margin (2024-2024)
10.14.4 ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Products Offered
10.14.5 ZodelBiotec Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Granulocytes Monoclonal Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Granulocytes Monoclonal Antibody Industrial Chain Analysis
11.4 Granulocytes Monoclonal Antibody Market Dynamics
11.4.1 Granulocytes Monoclonal Antibody Industry Trends
11.4.2 Granulocytes Monoclonal Antibody Market Drivers
11.4.3 Granulocytes Monoclonal Antibody Market Challenges
11.4.4 Granulocytes Monoclonal Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Granulocytes Monoclonal Antibody Distributors
12.3 Granulocytes Monoclonal Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Recombinant
Table 2. Major Company of Non-recombinant
Table 3. Global Granulocytes Monoclonal Antibody Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (K Units)
Table 5. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US& Million)
Table 7. Global Granulocytes Monoclonal Antibody Market Share in Value by Type (2024-2024)
Table 8. Global Granulocytes Monoclonal Antibody Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Granulocytes Monoclonal Antibody Sales by Type (2024-2034) & (K Units)
Table 10. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Granulocytes Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Granulocytes Monoclonal Antibody Sales Market Share in Value by Type (2024-2034)
Table 13. Global Granulocytes Monoclonal Antibody Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (K Units)
Table 15. North America Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2024)
Table 17. Europe Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2024)
Table 21. Latin America Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Granulocytes Monoclonal Antibody Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Granulocytes Monoclonal Antibody Sales by Company (2024-2024) & (K Units)
Table 25. Global Granulocytes Monoclonal Antibody Sales Share by Company (2024-2024)
Table 26. Global Granulocytes Monoclonal Antibody Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Granulocytes Monoclonal Antibody Revenue Share by Company (2024-2024)
Table 28. Global Market Granulocytes Monoclonal Antibody Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Granulocytes Monoclonal Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Granulocytes Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Granulocytes Monoclonal Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into Granulocytes Monoclonal Antibody Market
Table 33. Key Manufacturers Granulocytes Monoclonal Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Granulocytes Monoclonal Antibody Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (K Units)
Table 37. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Granulocytes Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 40. Global Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 42. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Granulocytes Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 45. Global Granulocytes Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Granulocytes Monoclonal Antibody Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (K Units)
Table 48. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Granulocytes Monoclonal Antibody Sales Market Share in Value by Application (2024-2024)
Table 51. Global Granulocytes Monoclonal Antibody Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Granulocytes Monoclonal Antibody Sales by Application (2024-2034) & (K Units)
Table 53. Global Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Granulocytes Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Granulocytes Monoclonal Antibody Sales Market Share in Value by Application (2024-2034)
Table 56. Global Granulocytes Monoclonal Antibody Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Granulocytes Monoclonal Antibody Sales by Application (2024-2024) (K Units)
Table 58. North America Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Granulocytes Monoclonal Antibody Sales by Application (2024-2024) (K Units)
Table 60. Europe Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Granulocytes Monoclonal Antibody Sales by Application (2024-2024) (K Units)
Table 64. Latin America Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 68. North America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 71. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 72. North America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 76. Europe Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 80. Europe Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Granulocytes Monoclonal Antibody Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Granulocytes Monoclonal Antibody Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Value by Country (2024-2034)
Table 107. LifeSpan BioSciences, Inc Company Information
Table 108. LifeSpan BioSciences, Inc Introduction and Business Overview
Table 109. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. LifeSpan BioSciences, Inc Granulocytes Monoclonal Antibody Product
Table 111. LifeSpan BioSciences, Inc Recent Development
Table 112. Thermo Fisher Company Information
Table 113. Thermo Fisher Introduction and Business Overview
Table 114. Thermo Fisher Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Thermo Fisher Granulocytes Monoclonal Antibody Product
Table 116. Thermo Fisher Recent Development
Table 117. RayBiotech, Inc. Company Information
Table 118. RayBiotech, Inc. Introduction and Business Overview
Table 119. RayBiotech, Inc. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. RayBiotech, Inc. Granulocytes Monoclonal Antibody Product
Table 121. RayBiotech, Inc. Recent Development
Table 122. MyBiosource, Inc. Company Information
Table 123. MyBiosource, Inc. Introduction and Business Overview
Table 124. MyBiosource, Inc. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. MyBiosource, Inc. Granulocytes Monoclonal Antibody Product
Table 126. MyBiosource, Inc. Recent Development
Table 127. Shanghai Korain Biotech Co., Ltd. Company Information
Table 128. Shanghai Korain Biotech Co., Ltd. Introduction and Business Overview
Table 129. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Shanghai Korain Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product
Table 131. Shanghai Korain Biotech Co., Ltd. Recent Development
Table 132. Wuhan Fine Biotech Co., Ltd. Company Information
Table 133. Wuhan Fine Biotech Co., Ltd. Introduction and Business Overview
Table 134. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Wuhan Fine Biotech Co., Ltd. Granulocytes Monoclonal Antibody Product
Table 136. Wuhan Fine Biotech Co., Ltd. Recent Development
Table 137. CUSABIO Company Information
Table 138. CUSABIO Introduction and Business Overview
Table 139. CUSABIO Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. CUSABIO Granulocytes Monoclonal Antibody Product
Table 141. CUSABIO Recent Development
Table 142. Boster Biological Technology Company Information
Table 143. Boster Biological Technology Introduction and Business Overview
Table 144. Boster Biological Technology Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Boster Biological Technology Granulocytes Monoclonal Antibody Product
Table 146. Boster Biological Technology Recent Development
Table 147. Biomatik Company Information
Table 148. Biomatik Introduction and Business Overview
Table 149. Biomatik Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Biomatik Granulocytes Monoclonal Antibody Product
Table 151. Biomatik Recent Development
Table 152. Assay Genie Company Information
Table 153. Assay Genie Introduction and Business Overview
Table 154. Assay Genie Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Assay Genie Granulocytes Monoclonal Antibody Product
Table 156. Assay Genie Recent Development
Table 157. Abbexa Company Information
Table 158. Abbexa Introduction and Business Overview
Table 159. Abbexa Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Abbexa Granulocytes Monoclonal Antibody Product
Table 161. Abbexa Recent Development
Table 162. CLOUD-CLONE CORP. Company Information
Table 163. CLOUD-CLONE CORP. Introduction and Business Overview
Table 164. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. CLOUD-CLONE CORP. Granulocytes Monoclonal Antibody Product
Table 166. CLOUD-CLONE CORP. Recent Development
Table 167. Innovative Research Company Information
Table 168. Innovative Research Introduction and Business Overview
Table 169. Innovative Research Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Innovative Research Granulocytes Monoclonal Antibody Product
Table 171. Innovative Research Recent Development
Table 172. ZodelBiotec Ltd. Company Information
Table 173. ZodelBiotec Ltd. Introduction and Business Overview
Table 174. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. ZodelBiotec Ltd. Granulocytes Monoclonal Antibody Product
Table 176. ZodelBiotec Ltd. Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Granulocytes Monoclonal Antibody Market Trends
Table 180. Granulocytes Monoclonal Antibody Market Drivers
Table 181. Granulocytes Monoclonal Antibody Market Challenges
Table 182. Granulocytes Monoclonal Antibody Market Restraints
Table 183. Granulocytes Monoclonal Antibody Distributors List
Table 184. Granulocytes Monoclonal Antibody Downstream Customers
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Granulocytes Monoclonal Antibody Product Picture
Figure 2. Global Granulocytes Monoclonal Antibody Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Granulocytes Monoclonal Antibody Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Granulocytes Monoclonal Antibody Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Recombinant
Figure 6. Global Recombinant Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Non-recombinant
Figure 8. Global Non-recombinant Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Granulocytes Monoclonal Antibody Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Granulocytes Monoclonal Antibody Sales Market Share by Type in 2022 & 2034
Figure 11. North America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America Granulocytes Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe Granulocytes Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Granulocytes Monoclonal Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Granulocytes Monoclonal Antibody Revenue in 2022
Figure 23. Granulocytes Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Flow Cytometry
Figure 25. Global Flow Cytometry Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of ELISA
Figure 27. Global ELISA Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Western Blot
Figure 29. Global Western Blot Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Immunoprecipitation
Figure 31. Global Immunoprecipitation Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Immunofluorescence
Figure 33. Global Immunofluorescence Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Granulocytes Monoclonal Antibody Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Granulocytes Monoclonal Antibody Sales Market Share by Application in 2022 & 2034
Figure 38. North America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America Granulocytes Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe Granulocytes Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Granulocytes Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Granulocytes Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Granulocytes Monoclonal Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Granulocytes Monoclonal Antibody Manufacturing Cost Structure
Figure 49. Granulocytes Monoclonal Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed